European Patent Approved for CytoDyn

European Patent Approved for CytoDyn

Business Wire - November 10, 2003

LOS ANGELES--The European Patent Office has approved the first of four pending patents licensed to CytoDyn, Inc. The new European patent covers the use of Cytolin to treat HIV/AIDS and is equivalent to U.S. Patent No. 5,424,066, one of three U.S. patents licensed to CytoDyn by scientist Allen D. Allen, who serves as CytoDyn's Chairman.

Cytolin is a monoclonal antibody that has shown considerable promise as a treatment for HIV/AIDS during clinical trials and during the extensive off-label use of Cytolin that occurred at the height of the AIDS epidemic in the United States. Similar products have been generating billions of dollars in sales for other developers of therapeutic antibodies.

CytoDyn believes European patents are of considerable strategic importance because many of the pharmaceutical companies that would be appropriate strategic partners for CytoDyn after it has completed its Phase 2 study of Cytolin are multinational corporations headquartered in Europe.

For further details and contacts: www.cytodyn.com

CytoDyn and Cytolin are the registered trademarks of CytoDyn, Inc.

CONTACT: CytoDyn, Inc.

Allen D. Allen, 818/501-8737

SOURCE: CytoDyn, Inc.

031110
BW031106

Copyright © 2003 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .